Skip to content

Erectus Nerve Block for Lumbar Spine Surgery

Erectus Nerve Block for Lumbar Spine Surgery : a Prospective Randomized Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04473508
Acronym
EFABE
Enrollment
50
Registered
2020-07-16
Start date
2019-11-27
Completion date
2021-09-09
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AdverseEvent, Morphine, Pain Relief, Spine Surgery

Brief summary

: Spine surgery induced severe postoperative pain. Several techniques as intravenous multimodal analgesia have been proposed to reduce pain relief and morphine rescue over the first postoperative days. Regional anesthesia using the erectus nerve block is a simple infiltration across lamina of the vertebra: Ultrasound-guided posterior ramus of spinal nerve block for anesthesia and analgesia in lumbar spinal surgery This study compared erector nerve block with local anesthetic vs placebo to reduce pain and morphine rescue after lumbar spine surgery. The investigators hypothesized that eructor nerve block induced a large block from L1 to L5 that induced posterior nerve roots block anesthesia. This block reduced pain after surgery.

Interventions

DRUGLocal administration of ropivacaine

Erector nerve block with local ropivacaine injection in addition with conventional anesthesia for spine surgery

DRUGLocal administration of placebo (saline solution)

injection of saline solution in addition with conventional anesthesia for spine surgery

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age\> 18years and \<80 years * lumbar spine surgery (2-4 levels) * posterior approach * ASA 1-3

Exclusion criteria

* refusal * age \< 18yrs * \<50 kg and \>120 kg * pregnant * renal or hepatic severe desease * ASA 4 * no French speaking * emergency surgery * local or systemic infection * surgical resumption of the surgical site * surgery involving a thoracic approach * allergy to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
morphine consumption (mg)24 Hours after surgeryQuantity administered in the post-interventional monitoring room and in hospitalization via a self-controlled morphine pump by the patient

Secondary

MeasureTime frameDescription
pain at rest and at movement: Visual Analogic scaleDay 1 to Day 3, Day od hospital discharge and month 3Visual Analogic scale of pain (0-10)
chronic pain: DN4 questionnaireQuestionnaire DN4 at 3 monthspain score as mesured with DN4 questionnaire
Length of hospital stayhospital length of stay, an average of 4 daysNumber of day in hospital
Adverse eventsfrom surgery to 3 monthsNausea, vomiting, confusion, urinary retention, hematoma, reintervention
Patient Satisfaction: visual analogic scaleDay of hospital discharge, an average of day 4Patient satisfaction mesured with a visual analogic scale (0-10)
Patient Quality of life: EQ-5D Questionnaire3 monthsPatient Quality of life mesured with EQ-5D Questionnaire
Length of stay in the post-intervention care unitDay 1Number of minutes that patient stay in post intervention care unit in minutes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026